Answers are grounded in this paper and cite their sources.
Article abstract Hematologic complications secondary to diphenylhydantoin therapy generally have been considered to be unusual hypersensitivity or idiosyncratic reactions on an im-munologic basis. This paper reports a case of a diphenylhydantoin-induced blood dyscrasia manifested by panrnyeloid hypoplasia. The dose-dependent toxicity was reproducible and a function of elevated diphenylhydantoin serum levels, suggesting the possibility of a direct toxic effect.
No takes yet. Share an insight, caveat, or question.
Parker et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: